Bisphosphonates and osteonecrosis of the jaw.

Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med (2008) 1.85

Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract (2006) 1.84

Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int (2007) 1.64

Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study. BMC Musculoskelet Disord (2011) 1.37

Skeletal complications of breast cancer therapies. Clin Cancer Res (2006) 1.16

Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Clin Cases Miner Bone Metab (2007) 1.06

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporos Int (2008) 0.99

Dried plum's unique capacity to reverse bone loss and alter bone metabolism in postmenopausal osteoporosis model. PLoS One (2013) 0.92

[Bisphosphonate-associated osteonecrosis of the jaw]. Mund Kiefer Gesichtschir (2006) 0.92

Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role. Arthritis Res Ther (2006) 0.90

Intravenous bisphosphonates for postmenopausal osteoporosis. J Res Med Sci (2010) 0.90

Once-yearly zoledronic acid in hip fracture prevention. Clin Interv Aging (2009) 0.86

Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin Oral Investig (2009) 0.83

[Osteonecrosis of the jaws by long term therapy with bisphosphonates]. Mund Kiefer Gesichtschir (2006) 0.81

Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease. Rheumatol Int (2013) 0.81

HIF targets in bone remodeling and metastatic disease. Pharmacol Ther (2015) 0.79

Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats. PLoS One (2015) 0.78

Bisphosphonate-related osteonecrosis of the jaw: the Florence experience. Clin Cases Miner Bone Metab (2007) 0.77

Differences between the bisphosphonates for the prevention and treatment of osteoporosis. Ther Clin Risk Manag (2006) 0.77

Osteonecrosis of the myeloma patients treated with bisphosphonates. Clin Cases Miner Bone Metab (2007) 0.75

Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents. Yonago Acta Med (2016) 0.75

Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report. Head Neck Pathol (2007) 0.75

Bone-Fat Interaction. Endocrinol Metab Clin North Am (2016) 0.75

Risk factors for rhabdomyolysis with simvastatin and atorvastatin. Drug Saf (2006) 1.60

Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf (2014) 1.14

Tramadol and seizures. Med J Aust (2005) 0.95

A novel route for the inclusion of metal dopants in silicon. Nanotechnology (2009) 0.75